Landmark pancreatic cancer drug shows potential against lung cancer too
Nature ·
Landmark pancreatic cancer drug shows potential against lung cancer too
Ledford
- In the news
The AI brief for this paper is being written. Open it in JClub to read the paper with the brief as soon as it lands.
Read the brief in JClub →Why it is on JClub this week
Covered by 1 news source.
- News stories
- 1
- news
- carry
Signals for the week to 3 Oct 2026 · everything that moved →
Related in JClub
Cancer Discovery · · News
Next-generation tyrosine kinase inhibitor sunvozertinib shows superior efficacy over chemotherapy as a first-line treatment for EGFR exon 20 insertion non-small cell lung cancer in the phase III WU-KONG28 trial.
- In the news
Cancer Discovery · · News
Ivonescimab combined with chemotherapy improves overall survival in advanced squamous NSCLC, showing a significant benefit over existing immunotherapy-chemotherapy regimens in a Chinese trial.
- In the news
Cancer Discovery · · News
A 14-protein blood test predicts lung cancer risk over 5 years before detection, including in never-smokers outside current screening guidelines.
- In the news